Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,373,771
+$1,476,916 QoQ
Shares Held
5,314
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#1,536
of 4,621 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Sheridan Advisors LLC holds $58,603,256 across 10 Drug Manufacturers - General names. LLY ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,432 | $17,220,228 | |
| 2 | JNJ |
Johnson & Johnson
|
50,589 | $12,848,088 | |
| 3 | MRK |
Merck & Co., Inc.
|
98,070 | $12,601,995 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
5,314 | $6,373,771 | |
| 5 | AMGN |
Amgen Inc
|
8,505 | $3,079,830 | |
| 6 | PFE |
Pfizer Inc
|
120,987 | $2,913,366 | |
| 7 | NVS |
Novartis AG
|
13,967 | $2,188,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,810 | $607,695 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,373,771 | 5,314 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $4,896,855 | 5,324 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,457,225 | 5,078 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,849,335 | 5,045 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,795,531 | 4,869 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,023,833 | 4,872 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $3,775,080 | 4,890 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,289,721 | 4,842 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,407,389 | 4,868 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,801,890 | 4,887 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,846,981 | 4,884 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,745,271 | 5,111 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,434,475 | 5,191 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,015,492 | 2,957 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $764,605 | 2,090 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $678,064 | 2,097 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $745,080 | 2,298 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $608,536 | 2,125 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $577,852 | 2,092 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $411,731 | 1,782 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $415,201 | 1,809 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $345,990 | 1,852 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $287,365 | 1,702 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $310,990 | 2,101 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||